Stephens initiated coverage of Definitive Healthcare (DH) with an Equal Weight rating and $5 price target Definitive has “an impressive collection of data assets that have attracted a marquee customer base,” as well as a track record of expanding enterprise relationships, but this is all “still in early stages of coming together as a single, unified platform,” the analyst tells investors. The firm thinks investors need to see multiple, firm data points supporting a return to growth before re-rating the stock higher from here, the analyst added.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DH:
- Definitive Healthcare Reports Q3 Performance and Stock Buyback
- Definitive Healthcare sees Q4 adjusted EPS 7c, consensus 7c
- Definitive Healthcare raises FY24 adjusted EPS view to 34c-35c from 32c-34c
- Definitive Healthcare reports Q3 adjusted EPS 10c, consensus 8c
- Definitive Healthcare Announces CFO Departure and Stock Buyback